RecruitingNCT05490901

The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion

A Retrospective and Prospective Cohort Study to Investigate the Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion


Sponsor

Samsung Medical Center

Enrollment

400 participants

Start Date

Mar 17, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the role of exercise hemodynamic testing in the diagnostic workup for patients with dyspnea on exertion referred to the catheterization lab.


Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • Subject must be at least 19 years of age.
  • Patients with dyspnea on exertion
  • Written informed consent of participating subjects after being fully briefed (for prospective analysis)

Exclusion Criteria5

  • Patients with incomplete hemodynamic data at rest or exercise
  • Advanced tumor disease or other diseases with a short life expectancy
  • Uncontrolled systemic arterial hypertension ( \> 160/100 mmHg at rest)
  • FEV1\<50% predicted
  • TLC\<60% predicted

Interventions

DIAGNOSTIC_TESTExercise hemodynamic test

Assessment of pulmonary hemodynamics during exercise by right heart catheterization and cardiac function during exercise by a simultaneous transthoracic echocardiography


Locations(1)

Samsung Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05490901


Related Trials